|
1
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al: EAU guidelines on prostate cancer. Part 1:
Screening, diagnosis, and local treatment with curative
intent-update 2013. Eur Urol. 65:124–137. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nichol AM, Warde P and Bristow RG: Optimal
treatment of intermediate-risk prostate carcinoma with
radiotherapy: Clinical and translational issues. Cancer.
104:891–905. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lowrance WT, Eastham JA, Savage C,
Maschino AC, Laudone VP, Dechet CB, Stephenson RA, Scardino PT and
Sandhu JS: Contemporary open and robotic radical prostatectomy
practice patterns among urologists in the United States. J Urol.
187:2087–2092. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hull GW, Rabbani F, Abbas F, Wheeler TM,
Kattan MW and Scardino PT: Cancer control with radical
prostatectomy alone in 1,000 consecutive patients. J Urol.
167:528–534. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stephenson AJ, Kattan MW, Eastham JA,
Dotan ZA, Bianco FJ Jr, Lilja H and Scardino PT: Defining
biochemical recurrence of prostate cancer after radical
prostatectomy: A proposal for a standardized definition. J Clin
Oncol. 24:3973–3978. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
D'Amico AV, Chen MH, Roehl KA and Catalona
WJ: Preoperative PSA velocity and the risk of death from prostate
cancer after radical prostatectomy. N Engl J Med. 351:125–135.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
D'Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Horiguchi A, Nakashima J, Horiguchi Y,
Nakagawa K, Oya M, Ohigashi T, Marumo K and Murai M: Prediction of
extraprostatic cancer by prostate specific antigen density,
endorectal MRI, and biopsy Gleason score in clinically localized
prostate cancer. Prostate. 56:23–29. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ohori M, Kattan MW, Koh H, Maru N, Slawin
KM, Shariat S, Muramoto M, Reuter VE, Wheeler TM and Scardino PT:
Predicting the presence and side of extracapsular extension: A
nomogram for staging prostate cancer. J Urol. 171:1844–1849.
2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stephenson AJ, Shariat SF, Zelefsky MJ,
Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG,
Pistenmaa DA, et al: Salvage radiotherapy for recurrent prostate
cancer after radical prostatectomy. JAMA. 291:1325–1332.
2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yossepowitch O, Briganti A, Eastham JA,
Epstein J, Graefen M, Montironi R and Touijer K: Positive surgical
margins after radical prostatectomy: A systematic review and
contemporary update. Eur Urol. 65:303–313. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Negishi T, Kuroiwa K, Hori Y, Tomoda T,
Uchino H, Tokuda N, Furubayashi N, Nagase K, Iwai H and Nakamura M:
Predictive factors of late biochemical recurrence after radical
prostatectomy. Jpn J Clin Oncol. 47:233–238. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Blute ML, Bostwick DG, Bergstralh EJ,
Slezak JM, Martin SK, Amling CL and Zincke H: Anatomic
site-specific positive margins in organ-confined prostate cancer
and its impact on outcome after radical prostatectomy. Urology.
50:733–739. 1997.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Simon RM, Howard LE, Freedland SJ, Aronson
WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR and Vidal AC:
Adverse pathology and undetectable ultrasensitive prostate-specific
antigen after radical prostatectomy: Is adjuvant radiation
warranted? BJU Int. 117:897–903. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pettenati C, Neuzillet Y, Radulescu C,
Hervé JM, Molinié V and Lebret T: Positive surgical margins after
radical prostatectomy: What should we care about? World J Urol.
33:1973–1978. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Simon MA, Kim S and Soloway MS: Prostate
specific antigen recurrence rates are low after radical retropubic
prostatectomy and positive margins. J Urol. 175:140–145.
2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cao D, Kibel AS, Gao F, Tao Y and Humphrey
PA: The Gleason score of tumor at the margin in radical
prostatectomy is predictive of biochemical recurrence. Am J Surg
Pathol. 34:994–1001. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Humphrey PA: WHO clasification of tumors
of the prostate, pp138-162, 2016.
|
|
19
|
Stephenson AJ, Wood DP, Kattan MW, Klein
EA, Scardino PT, Eastham JA and Carver BS: Location, extent and
number of positive surgical margins do not improve accuracy of
predicting prostate cancer recurrence after radical prostatectomy.
J Urol. 182:1357–1363. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wright JL, Dalkin BL, True LD, Ellis WJ,
Stanford JL, Lange PH and Lin DW: Positive surgical margins at
radical prostatectomy predict prostate cancer specific mortality. J
Urol. 183:2213–2218. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Preston MA, Carrière M, Raju G, Morash C,
Doucette S, Gerridzen RG, Bella AJ, Eastham JA, Scardino PT and
Cagiannos I: The prognostic significance of capsular incision into
tumor during radical prostatectomy. Eur Urol. 59:613–618.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pound CR, Partin AW, Eisenberger MA, Chan
DW, Pearson JD and Walsh PC: Natural history of progression after
PSA elevation following radical prostatectomy. JAMA. 281:1591–1597.
1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Trock BJ, Han M, Freedland SJ, Humphreys
EB, DeWeese TL, Partin AW and Walsh PC: Prostate cancer-specific
survival following salvage radiotherapy vs observation in men with
biochemical recurrence after radical prostatectomy. JAMA.
299:2760–2769. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wiegel T, Bottke D, Steiner U, Siegmann A,
Golz R, Störkel S, Willich N, Semjonow A, Souchon R, Stöckle M, et
al: Phase III postoperative adjuvant radiotherapy after radical
prostatectomy compared with radical prostatectomy alone in pT3
prostate cancer with postoperative undetectable prostate-specific
antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 27:2924–2930.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bolla M, van Poppel H, Collette L, van
Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset
JF, van Velthoven R, et al: Postoperative radiotherapy after
radical prostatectomy: A randomised controlled trial (EORTC trial
22911). Lancet. 366:572–578. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Van der Kwast TH, Bolla M, Van Poppel H,
Van Cangh P, Vekemans K, Da Pozzo L, Bosset JF, Kurth KH, Schröder
FH and Collette L: EORTC 22911. Identification of patients with
prostate cancer who benefit from immediate postoperative
radiotherapy: EORTC 22911. J Clin Oncol. 25:4178–4186.
2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Resnick MJ, Canter DJ, Guzzo TJ,
Magerfleisch L, Tomaszewski JE, Brucker BM, Bergey MR, Sonnad SS,
Wein AJ and Malkowicz SB: Defining pathological variables to
predict biochemical failure in patients with positive surgical
margins at radical prostatectomy: Implications for adjuvant
radiotherapy. BJU Int. 105:1377–1380. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chapin BF, Nguyen JN, Achim MF, Navai N,
Williams SB, Prokhorova IN, Wang X, Tapia EM, Davis JW and Troncoso
P: Positive margin length and highest Gleason grade of tumor at the
margin predict for biochemical recurrence after radical
prostatectomy in patients with organ-confined prostate cancer.
Prostate Cancer Prostatic Dis. 21:221–227. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Preisser F, Coxilha G, Heinze A, Oh S,
Chun FK, Sauter G, Pompe RS, Huland H, Graefen M and Tilki D:
Impact of positive surgical margin length and Gleason grade at the
margin on biochemical recurrence in patients with organ-confined
prostate cancer. Prostate. 79:1832–1836. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Udo K, Cronin AM, Carlino LJ, Savage CJ,
Maschino AC, Al-Ahmadie HA, Gopalan A, Tickoo SK, Scardino PT,
Eastham JA, et al: Prognostic impact of subclassification of
radical prostatectomy positive margins by linear extent and Gleason
grade. J Urol. 189:1302–1307. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Viers BR, Sukov WR, Gettman MT, Rangel LJ,
Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA and
Karnes RJ: Primary Gleason grade 4 at the positive margin is
associated with metastasis and death among patients with Gleason 7
prostate cancer undergoing radical prostatectomy. Eur Urol.
66:1116–1124. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Walz J, Joniau S, Chun FK, Isbarn H,
Jeldres C, Yossepowitch O, Chao-Yu H, Klein EA, Scardino PT,
Reuther A, et al: Pathological results and rates of treatment
failure in high-risk prostate cancer patients after radical
prostatectomy. BJU Int. 107:765–770. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Marks RA, Koch MO, Lopez-Beltran A,
Montironi R, Juliar BE and Cheng L: The relationship between the
extent of surgical margin positivity and prostate specific antigen
recurrence in radical prostatectomy specimens. Hum Pathol.
38:1207–1211. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cao D, Humphrey PA, Gao F, Tao Y and Kibel
AS: Ability of linear length of positive margin in radical
prostatectomy specimens to predict biochemical recurrence. Urology.
77:1409–1414. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kawai H: Grneral rule for clinical and
pathological studies on prostate cancer: 70-71, 2010.
|
